Tocqueville Asset Management L.P. Bio Xcel Therapeutics, Inc. Put Options Transaction History
Tocqueville Asset Management L.P.
- $6.03 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding BTAI
# of Institutions
29Shares Held
5.36MCall Options Held
34.5KPut Options Held
59.4K-
Armistice Capital, LLC New York, NY4.32MShares$7.38 Million0.02% of portfolio
-
Black Rock Inc. New York, NY441KShares$753,5710.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny105KShares$179,5020.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny77.9KShares$133,2090.0% of portfolio
-
State Street Corp Boston, MA77.1KShares$131,9240.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $47.9M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...